Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
61,205.26 +278.24 (+0.46%) CMC Crypto 200
1,266.38 -91.63 (-6.75%)
Siemens Healthineers AG (SHL.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 05:19PM CEST
| Previous close | 52.58 |
| Open | 52.48 |
| Bid | 52.28 x 0 |
| Ask | 52.70 x 0 |
| Day's range | 52.48 - 52.72 |
| 52-week range | 44.46 - 58.16 |
| Volume | |
| Avg. volume | 957 |
| Market cap | 58.713B |
| Beta (5Y monthly) | 0.75 |
| PE ratio (TTM) | 38.98 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.95 (1.81%) |
| Ex-dividend date | 19 Apr 2024 |
| 1y target est | N/A |
- Business Wire
Siemens Healthineers launches Atellica CI Analyzer, compact testing system to tackle lab challenges
TARRYTOWN, N.Y., July 20, 2023--The newest addition to the Siemens Healthineers Atellica in vitro diagnostics portfolio, the Atellica CI Analyzer1 for immunoassay and clinical chemistry testing, has received FDA clearance and is now available in many of the world’s major markets. Labs operating at low to medium testing volumes will benefit from competitive advantages that the analyzer offers, including improved turnaround time predictability, advanced reporting functionality, and focused safety
© 2024 Yahoo. All rights reserved.